Anti-inflammatory effect of Sanshuibaihu decoction may be associated with nuclear factor-κB and p38 MAPKα in collagen-induced arthritis in rat

Journal of Ethnopharmacology

Volumn 127, Issue 2, 2010, Pages 264-273

  Yang, Min ^a   Xiao, Changhong ^a,b   Wu, Qifu ^a,b   Niu, Maochang ^c   Yao, Qi ^a   Li, Kaiqin ^b   Chen, Yuyao ^a   Shi, Caixia ^a   Chen, Dechao ^a   Feng, Guokai ^a   Xia, Chenlai ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b FIRST MILITARY MEDICAL UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Collagen induced arthritis; Nuclear factor B; p38 MAPK ; Rheumatoid arthritis; Sanshuibaihu decoction

Indexed keywords

ANEMARRHENA ASPHODELOIDES EXTRACT; ANGELICA SINENSIS EXTRACT; BRASSICA ALBA EXTRACT; CELASTRUS ORBICULATUS EXTRACT; CELASTRUS PANICULATUS EXTRACT; CHINESE DRUG; COLLAGEN TYPE 2; CYATHULA OFFICINALIS EXTRACT; GLYCYRRHIZA GLABRA EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEFLUNOMIDE; LONICERA JAPONICA EXTRACT; MINERAL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE ALPHA P38; NATURAL PRODUCT; PAEONIA LACTIFLORA EXTRACT; PAEONIA SUFFRUTICOSA EXTRACT; PLANT EXTRACT; POLYGONATUM CUSPIDATUM EXTRACT; REHMANNIA GLUTINOSA EXTRACT; SANSHUIBAIHU; SODIUM CHLORIDE; SPATHOLOBUS SUBERECTUS EXTRACT; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BARK; BONE DESTRUCTION; BRASSICA; BRASSICA ALBA; CARTILAGE DEGENERATION; CELASTRUS; CELASTRUS ORBICULATUS; CONTROLLED STUDY; CYATHULA OFFICINALIS; DRUG EFFICACY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HYPERPLASIA; IMAGE ANALYSIS; IN SITU HYBRIDIZATION; INFLAMMATORY INFILTRATE; MEDICINAL PLANT; NONHUMAN; PAW EDEMA; PLANT ROOT; PLANT SEED; PLANT STEM; POLYGONATUM; POLYGONATUM CUSPIDATUM; PROTEIN EXPRESSION; RAT; RHEUMATOID ARTHRITIS; RHIZOME; SCORING SYSTEM; SPATHOLOBUS SUBERECTUS; SYNOVITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; CATTLE; COLLAGEN TYPE II; DRUGS, CHINESE HERBAL; FEMALE; INFLAMMATION MEDIATORS; MITOGEN-ACTIVATED PROTEIN KINASE 14; NF-KAPPA B; RATS; RATS, WISTAR;

BOVINAE; RATTUS; RATTUS NORVEGICUS;

EID: 73749086758     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.11.010     Document Type: Article

References (63)

1. Acevedo-Vásquez E., Ponce-de-León D., and Gamboa-Cárdenas R. Latent infection and tuberculosis disease in rheumatoid arthritis patients. Rheumatic Disease Clinics of North America 35 (2009) 163-181
2. Alamanos Y., and Drosos A.A. Epidemiology of adult rheumatoid arthritis. Autoimmunity Reviews 4 (2005) 130-136
3. Blackwell T.S., and Christman J.W. The role of nuclear factor-kappa B in cytokine gene regulation. American Journal of Respiratory Cell and Molecular Biology 17 (1997) 3-9
4. Boissier M.C., Assier E., Biton J., Denys A., Falgarone G., and Bessis N. Regulatory T cells (Treg) in rheumatoid arthritis. Joint Bone Spine 76 (2009) 10-14
5. Bond C., and Cleland L.G. Rheumatoid arthritis: are pets implicated in its etiology?. Seminars in Arthritis and Rheumatism 25 (1996) 308-317
6. Bond M., Baker A.H., and Newby A.C. Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts. Biochemical and Biophysical Research Communications 264 (1999) 561-567
7. Borchers A.T., Keen C.L., Cheema G.S., and Gershwin M.E. The use of methotrexate in rheumatoid arthritis. Seminars in Arthritis and Rheumatism 34 (2004) 465-483
8. Brand D.D., Kang A.H., and Rosloniec E.F. Immunopathogenesis of collagen arthritis. Springer Seminars in Immunopathology 25 (2003) 3-18
9. Brook M., Sully G., Clark A.R., and Saklatvala J. Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade. FEBS Letters 483 (2000) 57-61
10. Brus H., Van de Laar M., Taal E., Rasker J., and Wiegman O. Compliance in rheumatoid arthritis and the role of formal patient education. Seminars in Arthritis and Rheumatism 26 (1997) 702-710
11. Bugatti S., Codullo V., Caporali R., and Montecucco C. B cells in rheumatoid arthritis. Autoimmunity Reviews 7 (2007) 137-142
12. Caporali R., Caprioli M., Bobbio-Pallavicini F., and Montecucco C. DMARDS and infections in rheumatoid arthritis. Autoimmunity Reviews 8 (2008) 139-143
13. Chang S.H., Sung H.C., Choi Y., Ko S.Y., Lee B.E., Baek D.H., Kim S.W., and Kim J.K. Suppressive effect of AIF, a water extract from three herbs, on collagen-induced arthritis in mice. International Immunopharmacology 5 (2005) 1365-1372
14. Chang Y., Wei W., Zhang L., and Xu H.M. Effects and mechanisms of total glucosides of paeony on synoviocytes activities in rat collagen-induced arthritis. Journal of Ethnopharmacology 121 (2009) 43-48
15. Chen P., and Zheng G. Chinese herbs and compatibility. In: Chen P., and Zheng G. (Eds). Advanced TCM Series (1999), IOS Press, Amsterdam 102-368
16. Chen Q., Deng W., Zhang S., Sun R., Yang S., Sun X., Hong G., Li L., Chang F., and Shen Y. Experimental design of traditional Chinese drug pharmacology. In: Sun Z., and Kuang L. (Eds). Experimental Methodology of Traditional Chinese Drug Pharmacology (2006), People's Medical Publishing House, Beijing 33-34
17. Costa-Neto E. Animal-based medicines: biological prospection and the sustainable use of zootherapeutic resources. Anais da Academia Brasileira de Ciências 77 (2005) 33-43
18. Costenbader K.H., Feskanich D., Mandl L.A., and Karlson E.W. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. The American Journal of Medicine 119 (2006) 503. e501-503.e509
19. Courtenay J.S., Dallman M.J., Dayan A.D., and Martin A. Mosedale B immunisation against heterologous type II collagen induces arthritis in mice. Nature 283 (1980) 666-668
20. Davis Iii J.M., and Matteson E.L. Cytokine biomarkers and the promise of personalized therapy in rheumatoid arthritis. Reumatología Clínica 5 (2009) 143-146
21. De Roos A.J., Cooper G.S., Alavanja M.C., and Sandler D.P. Rheumatoid arthritis among women in the agricultural health study: risk associated with farming activities and exposures. Annals of Epidemiology 15 (2005) 762-770
22. Deyl Z., Miksik I., and Eckhardt A. Preparative procedures and purity assessment of collagen proteins. Journal of Chromatography B 790 (2003) 245-275
23. Fleischmann R.M. Safety of biologic therapy in rheumatoid arthritis and other autoimmune diseases: focus on Rituximab. Seminars in Arthritis and Rheumatism 38 (2009) 265-280
24. Fortéa J.O., Bukulmez H., Petit-Teixeira E., Michou L., Pierlot C., Cailleau-Moindrault S., Lemaire I., Lasbleiz S., Alibert O., Quillet P., Bardin T., Prum B., Olson J.M., and Cornélis F. Dense genome-wide linkage analysis of rheumatoid arthritis, including covariates. Arthritis and Rheumatism 50 (2004) 2757-2765
25. Fournier C. Where do T cells stand in rheumatoid arthritis?. Joint Bone Spine 72 (2005) 527-532
26. Ganesan K., Tiwari M., Balachandran C., Manohar B., and Puvanakrishnan R. Estrogen and testosterone attenuate extracellular matrix loss in collagen-induced arthritis in rats. Calcified Tissue International 83 (2008) 354-364
27. Harigai E., Nakai S., Kawakita T., and Nomoto K. Combined treatment with Ren-shen-yang-rong-tang (Japanese name: Ninjin-youei-to) plus prednisolone on adjuvant-induced arthritis in Lewis rat. International Journal of Immunopharmacology 17 (1995) 411-418
28. Huandi W., Mengyue W., and Xiaobo L. Evaluation of the antipyretic activity of Gypsum Fibrosum and its constituents. Asian Journal of Traditional Medicines 4 (2009) 82-84
29. Huizinga T.W.J. Genetics in rheumatoid arthritis. Best Practice & Research Clinical Rheumatology 17 (2003) 703-716
30. James C., and Arthur K. Novel therapies for rheumatoid arthritis. Pathophysiology 12 (2005) 217-225
31. Källberg H., Padyukov L., Plenge R.M., Rönnelid J., Gregersen P.K., Van-der-Helm-van-Mil A.H.M., Toes R.E.M., Tom W., Huizinga L., and Klareskog L. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. The American Journal of Human Genetics 80 (2007) 867-875
32. Kavanaugh A. Economic consequences of established rheumatoid arthritis and its treatment. Best Practice & Research Clinical Rheumatology 21 (2007) 929-942
33. Kim J., Lee H., Lee Y., Oh B.G., Cho C., Kim Y., Shin M., Hong M., Jung S.K., and Bae H. Inhibition effects of Moutan Cortex Radicis on secretion of eotaxin in A549 human epithelial cells and eosinophil migration. Journal of Ethnopharmacology 114 (2007) 186-193
34. Kochi Y., Suzuki A., Yamada R., and Yamamoto K. Genetics of rheumatoid arthritis: underlying evidence of ethnic differences. Journal of Autoimmunity 32 (2009) 158-162
35. Korb A., Tohidast-Akrad M., Cetin E., Axmann R., Smolen J., and Schett G. Differential tissue expression and activation of p38 MAPK alpha, beta, gamma, and delta isoforms in rheumatoid arthritis. Arthritis and Rheumatism 54 (2006) 2745-2756
36. Lam F.F.Y., Ko I.W.M., Ng E.S.K., Tam L.S., Leung P.C., and Li E.K.M. Analgesic and anti-arthritic effects of Lingzhi and San Miao San supplementation in a rat model of arthritis induced by Freund's complete adjuvant. Journal of Ethnopharmacology 120 (2008) 44-50
37. Li X.L., Zhang Y.Q., and Huang T.H. Anti-inflammatory and analgesic effects of extract of Brassica alba. Research and Practice on Chinese Medicines 21 (2007) 28-30
38. Mackenzie A.R., and Dawson J. Could rheumatoid arthritis have an infectious aetiology?. Drug Discovery Today: Disease Mechanisms 2 (2005) 345-349
39. Martin-Mola E., and Balsa A. Infectious complications of biologic agents. Rheumatic Disease Clinics of North America 35 (2009) 183-199
40. Martinez-Gamboa L., Brezinschek H.-P., Burmester G.R., and Dörner T. Immunopathologic role of B lymphocytes in rheumatoid arthritis: rationale of B cell-directed therapy. Autoimmunity Reviews 5 (2006) 437-442
41. Mbalaviele G., Anderson G., Jones A., Ciechi P.D., Settle S., Mnich S., Thiede M., Abu-Amer Y., Portanova J., and Monahan J. Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction. Journal of Pharmacology and Experimental Therapeutics 317 (2006) 1044-1053
42. Morel J., and Berenbaum F. Signal transduction pathways: new targets for treating rheumatoid arthritis. Joint Bone Spine 71 (2004) 503-510
43. Ollendorf D.A., Klingman D., Hazard E., and Ray S. Differences in annual medication costs and rates of dosage increase between tumor necrosis factor-antagonist therapies for rheumatoid arthritis in a managed care population. Clinical Therapeutics 31 (2009) 825-835
44. Philip H., James W., Anthony R., Deborah T., and Heidi D. Current concepts in rheumatoid arthritis. In: Philip H., and James W. (Eds). The Foot and Ankle in Rheumatoid Arthritis (2007), Churchill Livingstone, Edinburgh 1-16
45. Reunanen N., Songping L., Ahonen M., Foschi M., Han J., and Kähäri V.M. Activation of p38α Mapk enhances collagenase-1 (matrix metalloproteinase (MMP-1)) and stromelysin-1 (MMP-3) expression by mRNA stabilization. The Journal of Biological Chemistry 277 (2002) 32360-62368
46. Sawada S., Takei M., Inomata H., Nozaki T., and Shiraiwa H. What is after cytokine-blocking therapy, a novel therapeutic target-Synovial Epstein-Barr virus for rheumatoid arthritis. Autoimmunity Reviews 6 (2007) 126-130
47. Setty A.R., and Sigal L.H. Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects. Seminars in Arthritis and Rheumatism 34 (2005) 773-784
48. Shakibaei M., Csaki C., Nebrich S., and Mobasheri A. Resveratrol suppresses interleukin-1[beta]-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochemical Pharmacology 76 (2008) 1426-1439
49. Shaochun B., Hongtao L., Kun-Hung C., Polikseni E., Harris P., Terry L.M., and Richard M.P. NF-kappaB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor alpha-mediated apoptosis. Arthritis and Rheumatism 50 (2004) 3844-3855
50. Symmons D.P.M. Environmental factors and the outcome of rheumatoid arthritis. Best Practice & Research Clinical Rheumatology 17 (2003) 717-727
51. Szodoray, P., Szabó, Z., Kapitány, A., Gyetvai, Á., Lakos, G., Szántó, S., Szücs, G., Szekanecz, Z., in press. Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmunity Reviews.
52. Tanida S., Yoshitomi H., Nishitani K., Ishikawa M., Kitaori T., Ito H., and Nakamura T. CCL20 produced in the cytokine network of rheumatoid arthritis recruits CCR6+ mononuclear cells and enhances the production of IL-6. Cytokine 47 (2009) 112-118
53. Taylor P.C. Antibody therapy for rheumatoid arthritis. Current Opinion in Pharmacology 3 (2003) 323-328
54. Tristano A.G. Tyrosine kinases as targets in rheumatoid arthritis. International Immunopharmacology 9 (2009) 1-9
55. Wang L.Q., Cui B.A., Zhang H.Y., Gao W.M., and Li S.L. Study on the anti inflammatory activity of the product extrouted from Flos Lonicerae Japonicae. China Animal Husbandry & Veterinary Medicine 5 (2008) 1560-1573
56. Weyand C.M., and Goronzy J.J. Pathomechanisms in rheumatoid arthritis-time for a string theory. Journal of Clinical Investigation 116 (2006) 869-871
57. Williams R.O., Paleolog E., and Feldmann M. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases. Current Opinion in Pharmacology 7 (2007) 412-417
58. Xiao C.H., Gu W.W., Zhang J.N., Chen G.Q., Huang S.F., Yang M., Chen D.C., Chen J., and Xiao D. Methanol extract of Celastrus orbiculatu suppresses synovial hyperplasia and cartilage erosion and degradation in rheumatoid arthritis. Journal of Southern Medical University 27 (2007) 945-950
59. Xiong C., Hua Z., Yuen Fan W., Ying X., Zhong Qiu L., Zhi Hong J., Zhao Xiang B., Hong Xi X., and Liang L. Suppressive effects of QFGJS, a preparation from an anti-arthritic herbal formula, on rat experimental adjuvant-induced arthritis. Biochemical and Biophysical Research Communications 337 (2005) 586-594
60. Xu H.M., Wei W., Jia X.Y., Chang Y., and Zhang L. Effects and mechanisms of total glucosides of paeony on adjuvant arthritis in rats. Journal of Ethnopharmacology 109 (2007) 442-448
61. Yang M., Xiao C.H., Wu Q.F., Chen D.C., and Huang S.F. Clinical observation of Sanshuibaihu decoction in 59 patients with active rheumatoid arthritis. New Journal of Traditional Chinese Medicine 38 (2006) 52-55
62. Yang M., Xiao C.H., Wu Q.F., and Li K.Q. Effects of SSBH on expression of TNF-α, MMP-1 and MMP-3 in collagen-induced arthritis, a preparation from an anti-arthritic Chinese herbal formula. China Journal of Modern Medicine 18 (2008) 1477-1481
63. Zheng Y.Q., and Wei W. Total glucosides of paeony suppresses adjuvant arthritis in rats and intervenes cytokine-signaling between different types of synoviocytes. International Immunopharmacology 5 (2005) 1560-1573